Loading...
OPKO Health, Inc.
OPK•NASDAQ
Healthcare
Medical - Diagnostics & Research
$1.35
$-0.02(-1.46%)
OPKO Health, Inc. (OPK) Financial Performance & Income Statement Overview
Review OPKO Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-17.41%
↓ 17.41%
Operating Income Growth
3.16%
↑ 3.16%
Net Income Growth
71.82%
↑ 71.82%
Operating Cash Flow Growth
-550.74%
↓ 550.74%
Operating Margin
-21.43%
↓ 21.43%
Gross Margin
32.12%
↑ 32.12%
Net Profit Margin
-5.66%
↓ 5.66%
ROE
-2.85%
↓ 2.85%
ROIC
-8.06%
↓ 8.06%
OPKO Health, Inc. (OPK) Income Statement & Financial Overview
Review OPKO Health, Inc.'s (OPK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $183.64M | $173.63M | $182.19M | $173.69M |
| Cost of Revenue | $98.98M | $133.50M | $150.95M | $153.05M |
| Gross Profit | $84.66M | $40.13M | $31.23M | $20.63M |
| Gross Profit Ratio | $0.46 | $0.23 | $0.17 | $0.12 |
| R&D Expenses | $30.43M | $28.77M | $24.08M | $21.94M |
| SG&A Expenses | $67.03M | $98.20M | $68.82M | $70.17M |
| Operating Expenses | $117.80M | $25.91M | $92.90M | $92.10M |
| Total Costs & Expenses | $216.78M | $159.42M | $243.86M | $245.16M |
| Interest Income | $4.29M | $2.93M | $391000.00 | $813000.00 |
| Interest Expense | $14.24M | $17.36M | $8.18M | $7.69M |
| Depreciation & Amortization | $24.04M | $24.16M | $24.16M | $25.82M |
| EBITDA | $73.18M | $89.94M | $21.75M | -$49.68M |
| EBITDA Ratio | $0.40 | $0.52 | $0.12 | -$0.29 |
| Operating Income | -$33.14M | $14.22M | -$61.67M | -$71.47M |
| Operating Income Ratio | -$0.18 | $0.08 | -$0.34 | -$0.41 |
| Other Income/Expenses (Net) | $68.12M | $34.20M | $51.09M | -$11.71M |
| Income Before Tax | $34.98M | $48.42M | -$10.58M | -$83.18M |
| Income Before Tax Ratio | $0.19 | $0.28 | -$0.06 | -$0.48 |
| Income Tax Expense | $20.90M | -$23.53M | -$280000.00 | -$1.35M |
| Net Income | $14.03M | $24.89M | -$10.30M | -$81.84M |
| Net Income Ratio | $0.08 | $0.14 | -$0.06 | -$0.47 |
| EPS | $0.02 | $0.04 | -$0.01 | -$0.12 |
| Diluted EPS | $0.02 | $0.02 | -$0.01 | -$0.12 |
| Weighted Avg Shares Outstanding | $676.79M | $694.62M | $697.21M | $706.88M |
| Weighted Avg Shares Outstanding (Diluted) | $951.84M | $998.36M | $697.21M | $706.88M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan